Search clinical trials for: Flowmax

Total 63 results

WellSpan Health

Completed

Effect of Tamsulosin on Stone Expulsion and Pain Resolution in ED Patients With Ureterolithiasis (Flowmax)

Kidney Stone

United States
The Cleveland Clinic

Withdrawn

Correlation Between FlowMet™ and Other Gold Standard Assessments in the Management of Critical Limb Ischemia (CLI)

Critical Limb Ischemia

United States
Otivio AS
Hannover Medical School; mediq Innovation Experts GmbH

Terminated

Intermittent Negative Pressure; Impact on Peripheral Artery Disease and Intermittent Claudication (FlowOx)

Intermittent Claudication | Peripheral Vascular Disease | Ischemia Limb | Critical Limb Ischemia | Walking, Difficulty

Germany
Oslo University Hospital
Otivio AS

Completed

Intermittent Negative Pressure to Improve Blood Flow in Patients With Peripheral Artery Disease: Effects After Long-term Treatment

Peripheral Arterial Disease | Intermittent Claudication

Norway
Otivio AS
The Research Council of Norway; European Union

Unknown

Effect on Blood Flow Using the FlowOx™ Device in Patients With Reduced Peripheral Circulation in the Lower Leg

Periferal Arterial Occlusive Disease, PAOD

Norway
Otivio AS
Haukeland University Hospital

Recruiting

Pilot Investigation to Evaluate FlowOx2.0™ for Experimental Treatment of Spasticity (FlowOx-MS)

Pain | Multiple Sclerosis | Spasticity, Muscle

Norway
Otivio AS

Enrolling by invitation

Performance and Long-term Safety of FlowOx2.0™, Multiple Sclerosis, Spasticity and Pain

Pain | Multiple Sclerosis | Spasticity, Muscle

Norway
Stanford University
National Heart, Lung, and Blood Institute (NHLBI); Medtronic Endovascular

Enrolling by invitation

The Use of FlowMet-R Technology to Predict Wound Healing in CLI Patients in a Wound Care Center Setting

Critical Limb Ischemia

United States
Eunice Kennedy Shriver National Institute of Child...

Suspended

A Noninvasive Multimodal Biosensing Device for Screening and Monitoring Response to Treatment of Infectious Respiratory Diseases

COVID-19 | Upper Respiratory Infection | Lower Respiratory Infection

United States
Oslo University Hospital
University of Oslo; Otivio AS

Terminated

The Effects of INP on Peripheral Circulation in Dialysis Patients and Patients With PAD and Leg Ulcers

Peripheral Arterial Disease | Renal Disease | Arterial Leg Ulcers

Norway
Boehringer Ingelheim

Completed

Study to Assess the Bioequivalence of Two Batches of Tamsulosin Hydrochloride in Healthy Male Subjects

Healthy
Medtronic Endovascular

Terminated

FlowMet-R Blood Flow Measurement for the Diagnosis of Peripheral Artery Disease and Critical Limb Ischemia

Peripheral Artery Disease

United States
University of California, Irvine

Enrolling by invitation

Trial of Tadalafil, Tamsulosin and Combination for Access Sheath Deployment

Nephrolithiasis

United States
Otivio AS

Active, not recruiting

Performance and Long-term Safety of FlowOx2.0™ in Patients With Multiple Sclerosis - Impact on Spasticity and Pain (FO-NP002)

Multiple Sclerosis | Spasticity, Muscle | Pain, Chronic

Sweden
Oslo University Hospital
Otivio AS

Completed

The Effects of Intermittent Negative Pressure on Wound Healing and Peripheral Circulation in Spinal Cord Injured Subjects

Wound Healing, Leg and Foot Ulcers, Macrocirculation, Microcirculation

Norway
Millennium Pharmaceuticals, Inc.

Terminated

Docetaxel With or Without TAK-117 (MLN1117) in Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

United States, Netherlands, Canada
University of Michigan

Terminated

Trial of Prophylactic Tamsulosin for Postoperative Urinary Retention in Primary Total Hip and Knee Arthroplasty Patients

Postoperative Urinary Retention

United States
Teva Pharmaceuticals USA

Completed

Tamsulosin Hydrochloride 0.4 mg Capsules Under Fed Conditions

Healthy

Canada
Siami, Paul F., M.D.
GlaxoSmithKline

Completed

Dutasteride and Flex Dose of Tamsulosin on as Needed Basis, to Treat Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States
Memorial Health University Medical Center

Unknown

Hernia Surgery Urinary Retention

Hernia | Urinary Retention

United States
Daewoong Pharmaceutical Co. LTD.

Completed

Clinical Trial to Evaluate the Efficacy and Safety of OLOMAX Tab

Hypertension | Dyslipidemias

Korea, Republic of
University of Wisconsin, Madison

Completed

Prevention of Post-operative Urinary Retention (POUR)

Urinary Tract Infections | Urinary Retention

United States
Robert Swor
William Beaumont Hospitals

Completed

The Efficacy of Tamsulosin in the Treatment of Ureteral Stones in Emergency Department Patients

Kidney Stones | Ureteral Stones

United States
Teva Pharmaceuticals USA

Completed

Tamsulosin Hydrochloride 0.4 mg Capsules Under Fasting Conditions

Healthy

Canada
Albert Einstein Healthcare Network

Terminated

Silodosin Versus Tamsulosin for Treatment of Ureteral Stones

Ureterolithiasis | Ureteral Stone | Ureteral Calculus

United States
Hackensack Meridian Health

Recruiting

Post Operative Urinary Retention (POUR) Following Thoracic Oncological Surgery

Urinary Retention

United States
Ascension Genesys Hospital

Completed

Preoperative Administration of Tamsulosin for Prevention of Post Operative Urinary Retention in Males Undergoing Elective Inguinal Hernia Repair

Postoperative Urinary Retention
University of Rochester

Terminated

Prophylactic Tamsulosin Use for Prevention of Post-Operative Urinary Retention

Post-Operative Urinary Retention

United States
Tabriz University

Unknown

Effect of Tamsulosin vs Prazosin in Treatment of Female Voiding Dysfunction

Neurogenic Bladder
University of California, San Francisco
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Active, not recruiting

Deprescribing Tamsulosin in Older Men (PERSONAL)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

United States
University of Zurich

Completed

Medical Expulsive Therapy of Single Distal Ureteral Stones

Ureteral Calculi

Switzerland
Emory University
ABRAHAM J & PHYLLIS KATZ FOUNDATION

Recruiting

Function of Tamsulosin in Older Males Undergoing Surgery With Indwelling Catheter (FOLI)

Postoperative Urinary Tract Infection

United States
Boehringer Ingelheim

Completed

Study of FLOMAX® Versus Placebo in Female Patients With Lower Urinary Tract Symptoms (LUTS) With a Significant Component of Voiding Symptoms

Lower Urinary Tract Symptoms
Anand Rughani, MD
MaineHealth

Completed

Decreasing Rates of Intraurethral Catheterization Postoperatively in Spine Surgery (DRIPS)

Post-operative Urinary Retention

United States
Boehringer Ingelheim

Completed

FLOMAX® Versus Placebo, in Male Patients With Acute Urinary Retention Related to Benign Prostatic Hyperplasia (BPH)

Prostate Hyperplasia
Boehringer Ingelheim

Completed

Study to Evaluate the Efficacy and Safety of Tamsulosin in Children With Neurogenic Bladder

Bladder, Neurogenic

Belgium, Spain, United States, India, South Africa, Philippines, Italy, Korea, Republic of, Russian Federation, Germany, Brazil, Mexico, Ukraine
Boehringer Ingelheim

Completed

Study to Evaluate the Symptomatic Relief Effects of FLOMAX® in Patients With Signs and Symptoms of Benign Prostatic Hyperplasia

Prostatic Hyperplasia
Emory University

Terminated

Efficacy of Flomax to Improve Stone Passage Following Shock Wave Lithotripsy

Urolithiasis

United States
VA Office of Research and Development

Completed

Effectiveness of onaBoNT-A vs Oral Tamsulosin in Men With BPH and LUTS

Benign Prostatic Hyperplasia | Lower Urinary Track Symptoms

United States
NeoTract, Inc.

Recruiting

Investigating Medication vs. Prostatic Urethral Lift: Assessment and Comparison of Therapies for BPH (IMPACT)

BPH

United States
Boehringer Ingelheim

Completed

FLOMAX® Versus HYTRIN® in Patients With the Signs and Symptoms of Benign Prostatic Hyperplasia

Prostatic Hyperplasia
Mayo Clinic

Recruiting

Use of Tamsulosin to Reduce the Incidence and Duration of Postoperative Urinary Retention Following Spine Surgery

Postoperative Urinary Retention

United States
University of Wisconsin, Madison

Completed

Treatment of Symptoms After Stent Placement for Urinary Tract Obstruction

Ureteral Obstruction

United States
St. Joseph's Healthcare Hamilton

Not yet recruiting

Efficacy And Safety Of Combination Therapy For Treatment Of Overactive Bladder In Male Patients With Benign Prostatic Hyperplasia.

Overactive Bladder | Benign Prostatic Hyperplasia

Canada
Kocatepe University

Completed

The Effects of α-adrenergic Receptor Antagonists on Choroid and Pupil

Benign Prostatic Hyperplasia | Choroid Disease | Pupil Anomaly
Astellas Pharma Inc

Completed

A Study to Evaluate Cardiovascular Interactions Between Mirabegron and Tamsulosin

Healthy Subjects | Pharmacokinetics | Cardiovascular

United Kingdom
Boehringer Ingelheim

Completed

Pharmacokinetics, Safety and Tolerability of Tamsulosin Hydrochloride in Children With Voiding Disorders

Urination Disorders
Timothy Boone, MD, PhD
Astellas Pharma US, Inc.

Completed

Pilot Trial Of Urinary Nerve Growth Factor (NGF) As Biomarker for Male Lower Urinary Tract Symptoms (LUTS)

Lower Urinary Tract Symptoms

United States
Astellas Pharma Global Development, Inc.

Completed

A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With OAB Symptoms While Taking Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) (PLUS)

Overactive Bladder | Benign Prostatic Hyperplasia

United States, Canada, Czechia, France, Germany, Italy, Poland, Spain, United Kingdom
Astellas Pharma Inc

Completed

Solifenacin Succinate With Tamsulosin HCl in Males With Lower Urinary Tract Symptoms and Bladder Outlet Obstruction

Lower Urinary Tract Symptoms | Bladder Outlet Obstruction

United States, Czech Republic, Poland, Hungary, Belgium, Germany

Search clinical trials for: Flowmax

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sweden

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations